Rheumatic Diseases
2
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Vaccine
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Alder TherapeuticsSweden - Solna
1 programExploring and Measuring the Impact of Steroids in Children and Young PeopleN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Oregon TherapeuticsHepatitis A vaccine
BiocorpT0001，10mg
Alder TherapeuticsExploring and Measuring the Impact of Steroids in Children and Young People
Clinical Trials (3)
Total enrollment: 255 patients across 3 trials
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Start: Oct 2022Est. completion: Aug 2026129 patients
Phase 4Active Not Recruiting
Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers
Start: Oct 2014Est. completion: Feb 201556 patients
Phase 1Completed
NCT07350395Alder TherapeuticsExploring and Measuring the Impact of Steroids in Children and Young People
Exploring and Measuring the Impact of Steroids in Children and Young People
Start: Nov 2025Est. completion: Dec 202670 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 255 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.